E
Barinthus Biotherapeutics plc BRNS
$1.20 $0.0151.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -100.01% 11,428.99%
Gross Profit 100.01% -11,428.99%
SG&A Expenses 18.58% 484.87%
Depreciation & Amortization -- --
Other Operating Expenses 55.17% 84.24%
Total Operating Expenses 6.72% 672.33%
Operating Income -6.72% -672.33%
Income Before Tax -7.47% 4.41%
Income Tax Expenses -13.64% -833.33%
Earnings from Continuing Operations -7.47% 4.53%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -80.00% -80.39%
Net Income -7.51% 4.34%
EBIT -6.72% -672.33%
EBITDA -7.32% -849.68%
EPS Basic -7.30% 4.59%
Normalized Basic EPS -5.71% -964.95%
EPS Diluted -6.86% 4.20%
Normalized Diluted EPS -5.71% -964.95%
Average Basic Shares Outstanding 0.19% 0.27%
Average Diluted Shares Outstanding 0.19% 0.27%
Dividend Per Share -- --
Payout Ratio -- --